Publication | Closed Access

Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment

NanoparticlesNanomedicineNeurodegenerative DiseasesAlzheimer's DiseaseEngineeringTherapeutic NanomaterialsNanotechnologyNanobiotechnologyCellular UptakeMedicineNano-drug DeliveryBiomedical EngineeringAnti-transferrin Receptor AntibodiesPharmacologyPlga NanoparticlesBiomolecular Engineering